Results of a Nationwide Screening for Anderson-Fabry Disease among Dialysis Patients

Journal of the American Society of Nephrology

Volumn 15, Issue 5, 2004, Pages 1323-1329

  Kotanko, Peter ^a   Kramar, Reinhard ^b   Devrnja, Danijela ^c   Paschke, Eduard ^c   Voigtländer, Till ^d   Auinger, Martin ^f   Demmelbauer, Klaus ^g   Lorenz, Matthias ^e   Hauser, Anna Christine ^e   Kofler, Hans Jörg ^h   Lhotta, Karl ⁱ   Neyer, Ulrich ^j   Pronai, Wolfgang ^k   Wallner, Manfred ^b   Wieser, Clemens ^l   Wiesholzer, Martin ^m   Zodl, Herbert ⁿ   Födinger, Manuela ^e   Sunder Plassmann, Gere ^e  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

^b Krankenhaus Wels   (Austria)

^c UNIVERSITY OF GRAZ   (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e UNIVERSITY OF VIENNA   (Austria)

^f GENERAL HOSPITAL LINZ   (Austria)

^g Hospital Ried im Innkreis   (Austria)

^h Salzburger Landeskliniken   (Austria)

ⁱ UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^j Landeskrankenhaus Feldkirch   (Austria)

^k KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

^l GENERAL HOSPITAL KLAGENFURT   (Austria)

^m Karl Landsteiner Institute for Implementation of Innovative Techniques in Cardiac Surgery   (Austria)

ⁿ Landesklinikum Wr Neustadt   (Austria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSIDASE;

ADULT; ARTICLE; AUSTRIA; BLOOD EXAMINATION; CASE REPORT; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FABRY DISEASE; GENE MUTATION; GENETIC SCREENING; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LYSOSOME STORAGE DISEASE; MALE; MASS SCREENING; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; X CHROMOSOME LINKED DISORDER;

EID: 11144355110     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000124671.61963.1E     Document Type: Article

References (25)

1. Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L: Enzymatic defect in Fabry's disease: Ceramidetrihexosidase deficiency. N Engl J Med 276: 1163-1167, 1967
2. Desnick RJ, Allen KY, Desnick SJ, Raman MK, Bernlohr RW, Krivit W: Fabry's disease: Enzymatic diagnosis of hemizygotes and heterozygotes: Alpha-galactosidase activities in plasma, serum, urine, and leukocytes. J Lab Clin Med 81: 157-171, 1973
3. McNary X, Löwenstein LA: A morphological study of the renal lesion in angiokeratoma corporis diffusum universale (Fabry's disease). J Urol 93: 641, 1965
4. Desnick RJ, Blieden LC, Sharp HL, Hofschire PJ, Moller JH: Cardiac valvular anomalies in Fabry disease: Clinical, morphologic, and biochemical studies. Circulation 54: 818-825, 1976
5. Elleder M, Bradova V, Smid F, Budesinsky M, Harzer K, Kustermann-Kuhn B, Ledvinova J, Belohlavek, Kral V, Dorazilova V: Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease: Report on a case simulating hypertrophic non-obstructive cardiomyopathy. Virchows Arch A Pathol Anat Histopathol 417: 449-455, 1990
6. von Scheidt W, Eng CM, Fitzmaurice TF, Erdmann E, Hubner G, Olsen EG, Christomanou H, Kandolf R, Bishop DF, Desnick RJ: An atypical variant of Fabry's disease with manifestations confined to the myocardium. N Engl J Med 324: 395-399, 1991
7. Meroni M, Sessa A, Battini G, Tazzari S, Torri Tarelli L: Kidney involvement in Anderson-Fabry disease. Contrib Nephrol 122: 178-184, 1997
8. Bernstein J, Churg J: Heritable metabolic diseases. In: Heptinstall's Pathology of the Kidney, edited by Jenette JC, Olson JL, Schwarts MM, Silva FG, Philadelphia, Lippincott-Raven, 1999, pp 1289-1292
9. Thadhani R, Wolf M, West ML, Tonelli M, Ruthazer R, Pastores GM, Obrador GT: Patients with Fabry disease on dialysis in the United States. Kidney Int 61: 249-255, 2002
10. Meikle PJ, Hopwood JJ, Clague AE, Carey WF: Prevalence of lysosomal storage disorders. JAMA 281: 249-254, 1999
11. Tsakiris D, Simpson HK, Jones EH, Briggs JD, Elinder CG, Mendel S, Piccoli G, dos Santos JP, Tognoni G, Vanrenterghem Y, Valderrabano F: Report on management of renale failure in Europe, XXVI, 1995: Rare diseases in renal replacement therapy in the ERA-EDTA Registry. Nephrol Dial Transplant 11[Suppl 7]: S4-20, 1996
12. Spada M, Pagliardini S: Screening for Fabry disease in end-stage nephropathies. J Inherit Metab Dis 25[Suppl 1]: 113, 2002
13. Utsumi K, Kase R, Takata T, Sakuraba H, Matsui N, Saito H, Nakamura T, Kawabe M, Iino Y, Katayama Y: Fabry disease in patients receiving maintenance dialysis. Clin Exp Nephrol 4: 49-51, 2000
14. Nakao S, Kodama C, Takenaka T, Tanaka A, Yasumoto Y, Yoshida A, Kanzaki T, Enriquez AL, Eng CM, Tanaka H, Tei C, Desnick RJ: Fabry disease: Detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype. Kidney Int 64: 801-807, 2003
15. Schiffmann R, Kopp JB, Austin HA 3rd, Sabnis S, Moore DF, Weibel T, Balow JE, Brady RO: Enzyme replacement therapy in Fabry disease: A randomized controlled trial. JAMA 285: 2743-2749, 2001
16. Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, Caplan L, Linthorst GE, Desnick RJ: Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease. N Engl J Med 345: 9-16, 2001
17. Lang T, Secic M: Annotated guidelines for authors, editors, and reviewers. In: How to Report Statistics In Medicine, Philadelphia, American College of Physicians, 1997
18. Lorenz M, Hauser AC, Püspök-Schwarz M, Kotanko P, Arias I, Zodl H, Kramar R, Paschke E, Voigtländer T, Sunder-Plassmann G: Anderson-Fabry disease in Austria. Wien Klin Wochenschr 115: 235-240, 2003
19. Linthorst GE, Hollak CE, Korevaar JC, Van Manen JG, Aerts JM, Boeschoten EW: Alpha-galactosidase A deficiency in Dutch patients on dialysis: A critical appraisal of screening for Fabry disease. Nephrol Dial Transplant 18: 1581-1584, 2003
20. Shimazu K, Tomiyoshi Y, Aoki S, Sakemi T, Sugihara H: Crescentic glomerulonephritis in a patient with heterozygous Fabry's disease. Nephron 92: 456-458, 2002
21. Singh HK, Nickeleit V, Kriegsmann J, Harris AA, Jennette JC, Mihatsch MJ: Coexistence of Fabry's disease and necrotizing and crescentic glomerulonephritis. Clin Nephrol 55: 73-79, 2001
22. Desnick RJ, Ioannou YA, Eng CM: Alpha-galactosidase A deficiency: Fabry disease. In: The Metabolic and Molecular Bases of Inherited Disease, 8th ed., edited by Scriver C, Beaudet A, Sly W, Valle D, New York, McGraw-Hill, 2001, pp 3733-3774
23. Cable WJ, McCluer RH, Kolodny EH, Ullman MD: Fabry disease: Detection of heterozygotes by examination of glycolipids in urinary sediment. Neurology 32: 1139-1145, 1982
24. Grimes DA, Schulz KF: Uses and abuses of screening tests. Lancet 359: 881-884, 2002
25. Desnick RJ, Brady R, Barranger J, Collins AJ, Germain DP, Goldman M, Grabowski G, Packman S, Wilcox WR: Fabry disease, an under-recognized multisystemic disorder: Expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138: 338-346, 2003